Gain insights about the health of your baby during pregnancy
Noninvasive prenatal Screening Tests (NIPT) can screen for trisomy 21 (Down syndrome) and other chromosomal abnormalities—as well as the sex of your baby—as early as nine weeks into your pregnancy, and with a high degree of accuracy.
GENOME-Flex, a new NIPT high risk pathway. Rapidly re-sequence previously run MaterniT 21 PLUS samples using MaterniT GENOME when late stage anomalies are suspected. Now you have options if a second NIPT is required.
This video explains what your MaterniT results mean and what next steps or other testing you might consider.
NOTE: The American College of Obstetricians and Gynecologists recommends that women with a “high risk” maternal serum screening result be offered diagnostic testing.1 Women with a “low risk” result often choose not to have diagnostic testing.
NOTE: Not even diagnostic testing can show all birth defects or genetic diseases. No test is perfect: even when all the results of diagnostic testing are normal, all pregnancies still have approximately a 3-5% risk of birth defects.